The chemical substance known as 1-[(3S,4R)-3-hydroxy-2,2-dimethyl-6-(pentafluoroethyl)-3,4-dihydro-2H-chromen-4-yl]piperidin-2-one, with the CAS number 131899-25-7, is a complex organic compound characterized by its unique structural features. It contains a piperidinone moiety, which contributes to its potential biological activity. The presence of a chromenyl group, specifically a dihydrochromen derivative, suggests that it may exhibit properties associated with flavonoids, such as antioxidant activity. The incorporation of a pentafluoroethyl group enhances its lipophilicity, potentially influencing its pharmacokinetic properties. Additionally, the stereochemistry indicated by the (3S,4R) configuration suggests that the compound may exhibit specific interactions with biological targets, which could be relevant in medicinal chemistry. Overall, this compound's structural complexity and functional groups position it as a candidate for further investigation in pharmaceutical applications, particularly in the development of novel therapeutic agents.

1-[(3S,4R)-3-hydroxy-2,2-dimethyl-6-(pentafluoroethyl)-3,4-dihydro-2H-chromen-4-yl]piperidin-2-one

131899-25-7: The chemical substance known as 1-[(3S,4R)-3-hydroxy-2,2-dimethyl-6-(pentafluoroethyl)-3,4-dihydro-2H-chromen-4-yl]piperidin-2-one, with the CAS number 131899-25-7, is a complex organic compound characterized by its unique structural features. It contains a piperidinone moiety, which contributes to its potential biological activity. The presence of a chromenyl group, specifically a dihydrochromen derivative, suggests that it may exhibit properties associated with flavonoids, such as antioxidant activity. The incorporation of a pentafluoroethyl group enhances its lipophilicity, potentially influencing its pharmacokinetic properties. Additionally, the stereochemistry indicated by the (3S,4R) configuration suggests that the compound may exhibit specific interactions with biological targets, which could be relevant in medicinal chemistry. Overall, this compound's structural complexity and functional groups position it as a candidate for further investigation in pharmaceutical applications, particularly in the development of novel therapeutic agents.

<p>BRL 55834, a potassium channel activator, has shown to relax airways and vasculature in vivo.</p>

CAS 131899-25-7

1-[(3S,4R)-3-hydroxy-2,2-dimethyl-6-(pentafluoroethyl)-3,4-dihydro-2H-chromen-4-yl]piperidin-2-one

BRL 55834

Ref: TM-T26905